Atea Pharmaceuticals AVIR
NASDAQ AVIR
$4.04 -0.01 (-0.25%)
At close: Oct 23, 2026 · 4:00 PM EDT

Atea Pharmaceuticals (AVIR) Sale and Maturity of Investments (2022 - 2026)

Updated

Analysis

Atea Pharmaceuticals (AVIR) Sale and Maturity of Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Atea Pharmaceuticals 324.03 Mn -782.58 Mn - 68.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 68.13 Mn
Mar 31, 2026 104.28 Mn
Dec 31, 2025 90.38 Mn
Sep 30, 2025 56.08 Mn
Jun 30, 2025 116.02 Mn
Mar 31, 2025 208.25 Mn
Dec 31, 2024 55.11 Mn
Sep 30, 2024 106.23 Mn
Jun 30, 2024 131.95 Mn
Mar 31, 2024 224.00 Mn
Dec 31, 2023 75.00 Mn
Sep 30, 2023 146.78 Mn
Jun 30, 2023 199.78 Mn
Mar 31, 2023 181.11 Mn
Dec 31, 2022 91.89 Mn
API Access

Atea Pharmaceuticals Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=AVIR&period=max&api_key=YOUR_API_KEY